Cargando…
Predicting Response to Anthracyclines in Ovarian Cancer
(1) Background: Anthracyclines are intriguing drugs, representing one of the cornerstones of both first and subsequent-lines of chemotherapy in ovarian cancer (OC). Their efficacy and mechanisms of action are related to the hot topics of OC clinical research, such as BRCA status and immunotherapy. P...
Autores principales: | Ferrero, Annamaria, Borghese, Martina, Restaino, Stefano, Puppo, Andrea, Vizzielli, Giuseppe, Biglia, Nicoletta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998349/ https://www.ncbi.nlm.nih.gov/pubmed/35409939 http://dx.doi.org/10.3390/ijerph19074260 |
Ejemplares similares
-
Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022) -
Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
por: Macchia, Gabriella, et al.
Publicado: (2023) -
Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015) -
Immunonutrition in ovarian cancer: clinical and immunological impact?
por: Ferrero, Annamaria, et al.
Publicado: (2022) -
A Rare Case of Hepatocellular Carcinoma Recurrence in Ovarian Site after 12 Years Mimicking a Hepatoid Adenocarcinoma: Case Report
por: Restaino, Stefano, et al.
Publicado: (2023)